Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Esperion Therapeutics Inc. has appointed Sheldon Koenig to ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Ann Arbor-based Esperion Therapeutics Inc. has named ...
ANN ARBOR, Mich., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the appointment of Sheldon Koenig, a proven leader in the cardiovascular market, as chief operating officer, ...
For Esperion Therapeutics, 2024 has marked a pivotal transformation in its mission to combat cardiovascular disease. CEO Sheldon Koenig, who brings over 25 years of cardiovascular industry experience, ...
Ladies and gentlemen, thank you for standing by, and welcome. At this time, all participants are in a listen-only. Following the presentation, there will be a question-and-answer session. Please be ...
ANN ARBOR, Mich., May 17, 2021 (GLOBE NEWSWIRE) -- ESPERION (NASDAQ: ESPR), today announced the appointment of Sheldon Koenig as president and chief executive officer and board member, effective ...
Esperion (NASDAQ: ESPR) Therapeutics, Inc.'s (NASDAQ:ESPR) President and CEO, Sheldon L. Koenig, has sold a total of 14,550 shares of the company's common stock. The transaction, which took place on ...
ANN ARBOR, Mich., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the appointment of Sheldon Koenig, a proven leader in the cardiovascular market, as chief operating officer, ...
-- Succeeds Tim Mayleben, who served as President and CEO for almost a decade and will continue to serve as a senior advisor – Mr. Mayleben added, “Sheldon has distinguished himself throughout his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback